Figure 2
From: Primary cardiac tumors on the verge of oblivion: a European experience over 15 years
(A) Mean survival for dignity matched groups (187.2 ± 2.7 months vs. 26.2 ± 9.8 months for benign versus malignant pathologies, p < 0.01). (B) Mean survival for gender matched groups with benign pathologies (188.0 ± 2.9 months versus 179.9 ± 5.1 months for female versus male gender). (C) Mean survival for gender matched groups with malignant pathologies (16.0 ± 5.1 months versus 22.5 ± 12.5 months for female versus male gender).